Skip to content

pn_blog-post_alert-logo_hubspot

PN_email_Headers_Alert-Banner

FDA Approves First Medication to Treat Tardive Dyskinesia

4/12/17 12:00 AM

The Food and Drug Administration on Tuesday announced it approved Ingrezza (valbenazine) capsules to...

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Subscribe Here!

cover_october 2025

News From Current Issue

AI-Induced Psychosis: A New Frontier in Mental Health
Anabolic Steroid Withdrawal Tied to Psychiatric Burden
From the Archives: 60 Years of Psychiatric News—Hot Off the Press

The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.